Appropriate nodal dissection during pulmonary resection improves pathologic staging accuracy. Detection of unexpected nodal metastases can be a surrogate for nodal dissection adequacy and reflect oncologic resection quality. The goal of this study is to determine if robotic lobectomy carries worse, same or better incidence of nodal upstaging as open lobectomy for clinical stage I non-small cell lung cancer (NSCLC).
Patients with clinical stage I NSCLC (< cT2aN0M0, AJCC 7th) who underwent lobectomy from 2010 through 2015, were abstracted from the National Cancer Database (NCDB). Propensity score matching was performed for robotic (n=7,452) and open (n=50,186) approaches. Primary outcomes were the number of lymph nodes (LN) examined, incidence of nodal upstaging, defined as unexpected hilar or mediastinal lymph node involvement. Secondary outcomes included resection margins and overall survival.
Matching generated 7,452 well matched pairs. There were no differences in nodal upstaging between robotic and open procedures [820 (11.0%) vs 863 (11.6%), p=0.28], despite more examined LN in the robotic group (10 vs 8, p<0.001). Incidence of positive margins (145 (2.0%) vs 178 (2.4%), p=0.071) was similar. The robotic group had lower 30 [73 (1.3%) vs 105 (1.9%), p=0.02], and 90-day mortality [125 (2.3%) vs 188 (3.5%), p<0.001). Five-year overall survival was similar between both groups (65.6% vs 66.7%, log-rank p=0.25).
Robotic lobectomy for clinical stage I NSCLC is an equivalent to open lobectomy as assessed by similar nodal upstaging rates, completeness of resection and overall survival. This suggests that the robotic technology has been adopted appropriately in early stage NSCLC.
Copyright © 2020. Published by Elsevier Inc.
Related Posts
The Cost-Effective Preparation of Green Fluorescent Carbon Dots for Bioimaging and Enhanced Intracellular Drug Delivery.
March 5, 2020
Autism-like behaviors and abnormality of glucose metabolism in offspring derived from aging males with epigenetically modified sperm.
October 15, 2020
Advertisement
Meeting Coverage
- ASCO – Lung CancerASCO.20 Virtual Scientific Program, held May 29 - 31, brought professionals from all over the world together to hear the brightest minds in oncology present state-of-the-art treatment modalities and new therapies.
- AACR-2020The American Association for Cancer Research is the world's oldest and largest professional association related to cancer research.
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.